Skip to main content

Evidence-Based Practices

The Foundation for Opioid Response and New York Community Trust are providing $750,000 to Housing Works for a program that aims to improve high-risk populations’ retention and adherence to medications for opioid use disorder.
Braeburn has requested final approval from the U.S. Food and Drug Administration for Brixadi, an injectable form of buprenorphine with weekly and monthly formulations.
Participants in a South Dakota alcohol-monitoring program that tests frequently for alcohol and swiftly imposes modest penalties for positive or missed tests were found to be less likely to be rearrested on drunk driving charges or have their probation revoked within the following year.
Sierra Tucson leaders have discovered biofeedback and neuromodulation techniques to be an ideal accelerator of treatment progress for patients with substance use disorders.
A review of Medicaid claims has found that more than two-thirds of adolescents and young adults who survived an opioid overdose received no treatment for opioid use disorder in the month following the event.
Walter Miley and Mary Woods of WestBridge speak about what differentiates WestBridge's care plans as they tackle the challenge of integrated treatment. By focusing and honing care plans to meet the…
Back to Top